Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RECOVER trial of convalescent plasma in high-risk hospitalized patients with severe COVID-19
2020-001632-10Phase 2Completed
- Sponsor
- Heidelberg University Hospital
- Start
- Apr 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in coronavirus disease 2019 (COVID-19) comparing Convalescent plasma plus standard of care with Standard of care (2 arms). Primary endpoint: Time to clinical improvement. Started Apr 2020; status: completed.
02
Drugs
COVID-19 convalescent plasma
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-001632-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001632-10.